Coverage
-
June 13, 2013
Promega Corp. can label its DNA fingerprinting products for forensic use, paternity testing, or research or clinical purposes, after a federal judge on Wednesday invalidated claims in a patent asserted by Life Technologies Corp. that discloses fluorescence-based DNA analysis.
1 other articles on this case.
View all »